Abstract S3-7: Treatment with Histone Deacetylase Inhibitors Creates ‘BRCAness’ and Sensitizes Human Triple Negative Breast Cancer Cells to PARP Inhibitors and Cisplatin
2013 ◽
2018 ◽
2018 ◽
Vol 37
(1)
◽
2016 ◽
Vol 28
(5)
◽
pp. 506-515
◽
2014 ◽
2019 ◽
Vol 845
◽
pp. 16-23
◽
2018 ◽
2016 ◽
Vol 17
(8)
◽
pp. 1235
◽
2015 ◽
Vol 14
(8)
◽
pp. 1848-1857
◽